L. Fan et al. / Bioorg. Med. Chem. Lett. 19 (2009) 3932–3933
3933
CHO
O
Et2N
O
3
a
O
O
O
R-NH
NHBOC
Et2N
O
O
4 R= CH2CO2Et
5 R= t-butyl
6 R= o-tolyl
b
O
O
R-NH
NH2 • TFA
O
Et2N
O
O
2 R= CH2CO2Et
7 R= t-butyl
Figure 2. Electrophysiological measurements using caged GABA 2. (A) Diagram of
the system used to measure GABAA receptor activity; (B) a representative current
trace in which the flash lamp was pulsed at the zero time point to induce photolysis.
8 R= o-tolyl
Scheme 1. Passerini route to DECM-caged GABA compounds. Reagents and
conditions: (a) BOCNH(CH2)3CO2H (1 equiv), CNCH2CO2Et (1 equiv), CH2Cl2 rt,
12 h, dark (96%); (b) CF3CO2H (5 equiv), CH2Cl2, rt, 18 h, dark (90%).
measurements of GABAA neurotransmitter receptors on cell sur-
faces without causing damage to key cellular constituents.
To remove the BOC group, freshly prepared samples of 4 were
exposed to TFA at rt, affording the desired caged DECM–GABA 2.
In like fashion, BOC–GABA compounds 5 and 6 were also deprotec-
ted to afford caged GABA salts 7 and 8, respectively.
Electrophysiological measurements with caged GABA 2 were
conducted as shown in Figure 2. A borosilicate pipette fitted with
an electrode (Fig. 2A) was attached to an HEK 293T cell transiently
expressing a GABAA receptor (alpha1, beta2, delta subunits). The
cell membrane was ruptured, exposing the cytosol to the pipette
buffer. The cell was lifted from the substratum and suspended in
Acknowledgments
Support of the Cornell NMR Facility has been provided by NSF
(CHE 7904825; PGM 8018643) and NIH (RR02002). This research
was supported in part byNIH (GM 04842).
Supplementary data
Supplementary data associated with this article can be found, in
front of a U-tube having a small (150 lm) opening for flowing solu-
tions of 2 over the cell surface. Solutions of 2 were kept on ice;
photolysis measurements were made at rt. An optical fiber posi-
tioned perpendicular to the U-tube directed light from a Rapp
SP-20 Xe flash-lamp onto the cell and surrounding buffer. A pulse
of 385–450 nm light released free GABA, activating the opening of
GABAA receptor-channels in the cell membrane and increasing the
permeability of the cell membrane to chloride ions. This resulted in
a rapid change in the current amplitude across the membrane as
measured by the pipette electrode (Fig. 2B).
References and notes
1. Noebels, J. L. Annu. Rev. Neurosci. 2003, 26, 599–625.
2. (a) Chang, Y.; Wang, R.; Barot, S.; Weiss, D. S. J. Neurosci. 1996, 16, 5415–5424;
(b) Baumann, S. W.; Baur, R.; Sigel, E. J. Biol. Chem. 2002, 277, 46020–46025.
3. Macdonald, R. L.; Gallagher, M. J.; Feng, H. J.; Kang, J. Biochem. Pharmacol. 2004,
68, 1497–1506.
4. Begley, C. E.; Famulari, M.; Annegers, J. F.; Lairson, D. R.; Reynolds, T. F.; Coan,
S.; Dubinsky, S.; Newmark, M. E.; Leibson, C.; So, E. L.; Rocca, W. A. Epilepsia
2000, 41, 342–351.
Like other coumarin-based caged compounds, GABA precursor 2
proved resistant to hydrolysis in the dark. Moreover, initial biolog-
ical experiments demonstrated that 2 was sufficiently soluble in
the assay buffer10 and was stable to hydrolysis. Upon photolysis
at 400 nm (Fig. 2B), 2 smoothly released GABA with a quantum
yield of 0.1. Moreover, no current was observed in the presence
of 2 or its photolysis byproduct(s). These characteristics suggest
that 2 and its congeners may prove useful in transient kinetic
5. (a) Hess, G. P. In Dynamic Studies in Biology Phototriggers; Goldner, M., Givens,
R., Eds.; Photoswitches and Caged Biomolecules; Wiley, 2005. Chapter 4.3; (b)
Hess, G. P. Biophys. Chem. 2003, 100, 493–506.
6. Shembekar, V. R.; Chen, Y.; Carpenter, B. K.; Hess, G. P. Biochemistry 2005, 44,
7107–7114.
7. Shembekar, V. R.; Carpenter, B. K.; Ramakrishnan, L.; Hess, G. P. Polym. Preprints
(American Chemical Society, Division of Polymer Chemistry 2004, 45, 893.
8. Review: Syamala, M. Org. Prep. Proc. Intl. 2005, 37, 103–171.
9. Ito, K.; Maruyama, J. Chem. Pharm. Bull. 1983, 31, 3014–3023.
10. Ramakrishnan, L.; Hess, G. P. Biochemistry 2004, 43, 7534–7540.